tradingkey.logo
tradingkey.logo
Search

Resmed Inc

RMD
Add to Watchlist
191.890USD
-1.020-0.53%
Close 07-23 16:00ETQuotes delayed by 15 min
27.83BMarket Cap
18.43P/E TTM
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-0.53%

5 Days

-5.36%

1 Month

+0.33%

6 Months

-23.97%

Year to Date

-20.33%

1 Year

-29.81%

Key Figures
190.450Open
192.510High
1.01MVolume
18.43P/E TTM
16.14P/E Dynamic
2.330Dividend TTM
0.70%Turnover Ratio
192.910Prev. Close
190.210Low
88.92MTurnover
19.87P/E Static
4.29P/B
1.21%Div Yield TTM
18.59%ROA
293.81052wk High
0.93Volume Ratio
1.40BNet Profit
145.04MShares
10.4102EPS TTM
0.83Beta
25.25%ROE
198.61052wk Low
1.19%Amplitude
61.46%Gross Margin
27.83BMarket Cap
-1.26Reward/Risk
1.45%Risk Rate

TradingKey Stock Score of Resmed Inc

Currency: USD Updated: 2026-07-23

Key Insights

Resmed Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 26 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 247.97.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Resmed Inc's Score

Industry at a Glance

Industry Ranking
26 / 200
Overall Ranking
79 / 4547
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

35°C

Very Low
Very High
Negative

Resmed Inc Highlights

StrengthsRisks
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 21.86% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 5.15B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 22.19%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 22.19%.
Undervalued
The company’s latest PE is 18.43, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 100.10M shares, decreasing 1.39% quarter-over-quarter.
Held by Ray Dalio
Star Investor Ray Dalio holds 42.60K shares of this stock.

Analyst Rating

Based on 21 analysts
Hold
Current Rating
247.967
Target Price
+26.64%
Upside Space

Earnings Forecast

Analyst Rating

Based on 21 analysts
Hold
Current Rating
247.967
Target Price
+26.64%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Resmed Inc
RMD
21
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18

Indicators

Indicators
Sell(2)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-2.595
Sell
RSI(14)
42.491
Neutral
STOCH(KDJ)(9,3,3)
17.317
Neutral
ATR(14)
7.129
Low Volatility
CCI(14)
-96.203
Neutral
Williams %R
94.786
Oversold
TRIX(12,20)
0.015
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
195.640
Sell
MA10
197.491
Sell
MA20
201.514
Sell
MA50
198.848
Sell
MA100
212.902
Sell
MA200
234.155
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Resmed Inc Info

ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Ticker SymbolRMD
CompanyResmed Inc
CEOFarrell (Michael J)
Websitehttps://www.resmed.com/

Shareholders

Shareholders
Shareholders
Proportion
Vanguard Capital Management, LLC
6.53%
BlackRock Institutional Trust Company, N.A.
6.03%
Vanguard Portfolio Management, LLC
5.42%
State Street Investment Management (US)
4.57%
Geode Capital Management, L.L.C.
2.97%
Other
74.49%

FAQs

What is the current price of Resmed Inc (RMD)?

The current price of Resmed Inc (RMD) is 191.89.

What is the symbol of Resmed Inc?

The ticker symbol of Resmed Inc is RMD.

What is the 52-week high of Resmed Inc?

The 52-week high of Resmed Inc is 293.81.

What is the 52-week low of Resmed Inc?

The 52-week low of Resmed Inc is 198.61.

What is the market capitalization of Resmed Inc?

The market capitalization of Resmed Inc is 27.83B.

Is Resmed Inc (RMD) currently rated as Buy, Hold, or Sell?

According to analysts, Resmed Inc (RMD) has an overall rating of signal_hold, with a price target of 247.97.

What is the Earnings Per Share (EPS TTM) of Resmed Inc (RMD)?

The Earnings Per Share (EPS TTM) of Resmed Inc (RMD) is 9.55.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.